TVARDI THERAPEUTICS, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
TVARDI THERAPEUTICS, INC. (TVRD) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $3.90 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-08-14
- 2026-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $3.90M.
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $4.40M.
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $3.80M.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $3.70M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2026-06-30 | $3.90M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $4.40M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $3.80M 10-K · filed 2026-03-31 |
| 2025-09-30 | $3.70M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $4.60M 10-Q · filed 2025-08-14 |
| 2019-12-31 | $22.22M 10-K · filed 2020-02-27 |
| 2018-12-31 | $20.47M 10-K · filed 2019-03-12 |
| 2017-12-31 | $15.91M 10-K · filed 2018-03-15 |
| 2016-12-31 | $7.82M 10-K · filed 2017-03-10 |
| 2015-12-31 | $7.04M 10-K · filed 2016-03-11 |
| 2014-12-31 | $3.77M 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |